Mallinckrodt Hit With Investor Suit After Mulling 2nd Ch. 11

By Henrik Nilsson · July 10, 2023, 10:10 PM EDT

Drugmaker Mallinckrodt PLC deceived shareholders that it had bounced back from bankruptcy and would be able to pay $200 million to an opioid fund, according to a proposed class action filed...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login